The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
Inhibitors of protein–protein interactions (PPIs): an analysis of scaffold choices and buried surface area
Open accessAbstract
Protein-protein interactions (PPI) were once considered “undruggable”, but clinical successes, driven by advanced methods in drug discovery, have challenged that notion. Here, we review the last three years of literature on PPI inhibitors to understand what is working and why. From the 66 recently reported PPI inhibitors, we found that the average molecular weight was significantly greater than 500 Da, but that this trend was driven, in large part, by the contribution of peptide-based compounds. Despite differences in average molecular weight, we found that compounds based on small molecules or peptides were almost equally likely to be potent inhibitors (KD < 1 μM). Finally, we found PPIs with buried surface area (BSA) less than 2000 Å2 were more likely to be inhibited by small molecules, while PPIs with larger BSA values were typically inhibited by peptides. PPIs with BSA values over 4000 Å2 seemed to create a particular challenge, especially for orthosteric small molecules. Thus, it seems important to choose the inhibitor scaffold based on the properties of the target interactions. Moreover, this survey suggests a (more nuanced) conclusion to the question of whether PPIs are good drug targets; namely, that some PPIs are readily “druggable” given the right choice of scaffold, while others still seem to deserve the “undruggable” moniker.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Benavides-Serrato, A., Lee, J., Holmes, B., Landon, K. A., Bashir, T., Jung, M. E., Lichtenstein, A. K., & Gera, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176599 · Cited by 89
RetractedUCSF Chimera—A visualization system for exploratory research and analysis
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 45,828
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416
Taxol stabilizes microtubules in mouse fibroblast cells.
Schiff, P. B., & Horwitz, S. B. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.3.1561 · Cited by 1,970
The resurgence of covalent drugs
Singh, J., Petter, R. C., Baillie, T. A., & Whitty, A. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3410 · Cited by 1,873 · cited 1×
“Finally, it seems that PROTACS molecules or covalent inhibitors [136] might be fundamentally new ways target the currently ‘undruggable’ systems.”
BackgroundInsulin-like growth factors and neoplasia
Pollak, M. N., Schernhammer, E. S., & Hankinson, S. E. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1387 · Cited by 1,463
Activation of Apoptosis in Vivo by a Hydrocarbon-Stapled BH3 Helix
Walensky, L. D., Kung, A. L., Escher, I., Malia, T. J., Barbuto, S., Wright, R. D., Wagner, G., Verdine, G. L., & Korsmeyer, S. J. (2004) · Science · doi:10.1126/science.1099191 · Cited by 1,349
Epigenetic protein families: a new frontier for drug discovery
Arrowsmith, C. H., Bountra, C., Fish, P. V., Lee, K., & Schapira, M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3674 · Cited by 1,327
Small-Molecule Inhibitors of Protein-Protein Interactions: Progressing toward the Reality
Arkin, M. R., Tang, Y., & Wells, J. A. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.09.001 · Cited by 1,065
Getting Across the Cell Membrane: An Overview for Small Molecules, Peptides, and Proteins
Yang, N. J., & Hinner, M. J. (2015) · Methods in Molecular Biology · doi:10.1007/978-1-4939-2272-7_3 · Cited by 826
Inhibition of α-helix-mediated protein–protein interactions using designed molecules
Azzarito, V., Long, K., Murphy, N. S., & Wilson, A. J. (2013) · Nature Chemistry · doi:10.1038/nchem.1568 · Cited by 727
Breaking Cryo-EM Resolution Barriers to Facilitate Drug Discovery
Merk, A., Bartesaghi, A., Banerjee, S., Falconieri, V., Rao, P., Davis, M. I., Pragani, R., Boxer, M. B., Earl, L. A., Milne, J. L. S., et al. (2016) · Cell · doi:10.1016/j.cell.2016.05.040 · Cited by 504
Protac-Induced Protein Degradation in Drug Discovery: Breaking the Rules or Just Making New Ones?
Churcher, I. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01272 · Cited by 491
BET Bromodomains Mediate Transcriptional Pause Release in Heart Failure
Anand, P., Brown, J. D., Lin, C. Y., Qi, J., Zhang, R., Artero, P. C., Alaiti, M. A., Bullard, J., Alazem, K., Margulies, K. B., et al. (2013) · Cell · doi:10.1016/j.cell.2013.07.013 · Cited by 406 · cited 1×
“Introduction Protein–protein interactions (PPIs) are potential drug targets for a broad range of therapeutic areas, such as oncology [1,2 ,3,4 ,5], immune-checkpoints for cancer immunotherapy [6], tropical infectious diseases [7 ], neurological disorders [8], heart failure [9] and inflammation”
BackgroundVillar, E. A., Beglov, D., Chennamadhavuni, S., Porco, J. A., Kozakov, D., Vajda, S., & Whitty, A. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1584 · Cited by 400
Pharmacologic Inhibition of the Menin-MLL Interaction Blocks Progression of MLL Leukemia In Vivo
Borkin, D., He, S., Miao, H., Kempinska, K., Pollock, J., Chase, J., Purohit, T., Malik, B., Zhao, T., Wang, J., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.02.016 · Cited by 392
Oncogenic protein interfaces: small molecules, big challenges
Nero, T. L., Morton, C. J., Holien, J. K., Wielens, J., & Parker, M. W. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3690 · Cited by 312
Non-peptide fibrinogen receptor antagonists. 1. Discovery and design of exosite inhibitors
Hartman, G. D., Egbertson, M. S., Halczenko, W., Laswell, W. L., Duggan, M. E., Smith, R. L., Naylor, A. M., Manno, P. D., & Lynch, R. J. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00102a020 · Cited by 301
Assessing Helical Protein Interfaces for Inhibitor Design
Bullock, B. N., Jochim, A. L., & Arora, P. S. (2011) · Journal of the American Chemical Society · doi:10.1021/ja206074j · Cited by 300
Smith, M. C., & Gestwicki, J. E. (2012) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2012.10 · Cited by 286
Self-citationCai, Q., Sun, H., Peng, Y., Lu, J., Nikolovska-Coleska, Z., McEachern, D., Liu, L., Qiu, S., Yang, C.-Y., Miller, R., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101505d · Cited by 272
Cimermancic, P., Weinkam, P., Rettenmaier, T. J., Bichmann, L., Keedy, D. A., Woldeyes, R. A., Schneidman-Duhovny, D., Demerdash, O. N., Mitchell, J. C., Wells, J. A., et al. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.01.029 · Cited by 268
Kawamoto, S. A., Coleska, A., Ran, X., Yi, H., Yang, C.-Y., & Wang, S. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201125d · Cited by 249
Self-citationFrost, J., Galdeano, C., Soares, P., Gadd, M. S., Grzes, K. M., Ellis, L., Epemolu, O., Shimamura, S., Bantscheff, M., Grandi, P., et al. (2016) · Nature Communications · doi:10.1038/ncomms13312 · Cited by 239
Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy
Picaud, S., Fedorov, O., Thanasopoulou, A., Leonards, K., Jones, K., Meier, J., Olzscha, H., Monteiro, O., Martin, S., Philpott, M., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0236 · Cited by 229
The EED protein–protein interaction inhibitor A-395 inactivates the PRC2 complex
He, Y., Selvaraju, S., Curtin, M. L., Jakob, C. G., Zhu, H., Comess, K. M., Shaw, B., The, J., Lima-Fernandes, E., Szewczyk, M. M., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2306 · Cited by 224
Li, Z., Ivanov, A. A., Su, R., Gonzalez-Pecchi, V., Qi, Q., Liu, S., Webber, P., McMillan, E., Rusnak, L., Pham, C., et al. (2017) · Nature Communications · doi:10.1038/ncomms14356 · Cited by 219
Allosteric small-molecule kinase inhibitors
Wu, P., Clausen, M. H., & Nielsen, T. E. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.10.002 · Cited by 204
Holzer, P., Masuya, K., Furet, P., Kallen, J., Valat-Stachyra, T., Ferretti, S., Berghausen, J., Bouisset-Leonard, M., Buschmann, N., Pissot-Soldermann, C., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00810 · Cited by 203
Arkin, M. R., & Whitty, A. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.05.125 · Cited by 190
Hot spots in protein–protein interfaces: Towards drug discovery
Cukuroglu, E., Engin, H. B., Gursoy, A., & Keskin, O. (2014) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2014.06.003 · Cited by 177
Macrocycles as protein–protein interaction inhibitors
Dougherty, P. G., Qian, Z., & Pei, D. (2017) · Biochemical Journal · doi:10.1042/bcj20160619 · Cited by 176
Boersma, M., Haase, H. S., Peterson‐Kaufman, K. J., Lee, E. F., Clarke, O. B., Colman, P. M., Smith, B. J., Horne, W. S., Fairlie, W. D., & Gellman, S. H. (2011) · Journal of the American Chemical Society · doi:10.1021/ja207148m · Cited by 157
SICLOPPS cyclic peptide libraries in drug discovery
Tavassoli, A. (2017) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2017.02.016 · Cited by 150
Protein–protein interactions as druggable targets: recent technological advances
Higueruelo, A. P., Jubb, H. C., & Blundell, T. L. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.05.009 · Cited by 142
Zhong, H.-J., Lu, L., Leung, K.-H., Wong, C. C. L., Peng, C., Yan, S.-C., Ma, D.-L., Cai, Z., David Wang, H.-M., & Leung, C.-H. (2015) · Chemical Science · doi:10.1039/c5sc02321a · Cited by 138
Validation of the Hsp70–Bag3 Protein–Protein Interaction as a Potential Therapeutic Target in Cancer
Li, X., Colvin, T. A., Rauch, J. N., Acosta‐Alvear, D., Kampmann, M., Dunyak, B. M., Hann, B. C., Aftab, B. T., Murnane, M., Cho, M. Y., et al. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0650 · Cited by 138
Self-citationBockus, A. T., Schwochert, J. A., Pye, C. R., Townsend, C. E., Sok, V., Bednarek, M. A., & Lokey, R. S. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00919 · Cited by 135
Lee, J. H., Zhang, Q., Jo, S., Chai, S. C., Oh, M., Im, W., Lu, H., & Lim, H. (2010) · Journal of the American Chemical Society · doi:10.1021/ja108230s · Cited by 130
Dietrich, L., Rathmer, B., Ewan, K., Bange, T., Heinrichs, S., Dale, T. C., Schade, D., & Grossmann, T. N. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.06.013 · Cited by 126
A small-molecule inhibitor of the aberrant transcription factor CBFβ-SMMHC delays leukemia in mice
Illendula, A., Pulikkan, J. A., Zong, H., Grembecka, J. E., Xue, L., Sen, S., Zhou, Y., Boulton, A. M., Kuntimaddi, A., Gao, Y., et al. (2015) · Science · doi:10.1126/science.aaa0314 · Cited by 124
Fine-Tuning Multiprotein Complexes Using Small Molecules
Thompson, A. D., Dugan, A. E., Gestwicki, J. E., & Mapp, A. K. (2012) · ACS Chemical Biology · doi:10.1021/cb300255p · Cited by 115
Self-citationStructure-Based Design of γ-Carboline Analogues as Potent and Specific BET Bromodomain Inhibitors
Xu, R., Zhao, Y., Liu, L., Bai, L., Yang, C., Zhou, B. N., Meagher, J. L., Chinnaswamy, K., Stuckey, J. A., & Wang, S. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00613 · Cited by 113
Moving Beyond Active-Site Detection: MixMD Applied to Allosteric Systems
Ghanakota, P., & Carlson, H. A. (2016) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.6b03515 · Cited by 108
Peptidomimetic inhibitors of APC–Asef interaction block colorectal cancer migration
Jiang, H., Deng, R., Yang, X., Shang, J., Lu, S., Zhao, Y., Song, K., Liu, X., Zhang, Q., Chen, Y., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2442 · Cited by 102
Karataş, H., Li, Y., Liu, L., Ji, J., Lee, S. H. F., Chen, Y., Yang, J., Huang, L., Bernard, D., Xu, J., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01796 · Cited by 101
Qian, Z., Rhodes, C. A., McCroskey, L. C., Wen, J., Appiah‐Kubi, G., Wang, J., Guttridge, D. C., & Pei, D. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201610888 · Cited by 100
Janecek, M., Rossmann, M., Sharma, P., Emery, A., Huggins, D. J., Stockwell, S. R., Stokes, J. E., Tan, Y. S., Guarino, E., Hardwick, B. S., et al. (2016) · Scientific Reports · doi:10.1038/srep28528 · Cited by 99
Jiang, Z., Xu, L., Lu, M., Chen, Z., Yuan, Z., Xu, X., Guo, X., Zhang, X., Sun, H.-P., & You, Q. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00185 · Cited by 94
Lowell, A. N., DeMars, M. D., Slocum, S. T., Yu, F., Anand, K., Chemler, J. A., Korakavi, N., Priessnitz, J. K., Park, S. R., Koch, A. A., et al. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b02875 · Cited by 92
BCL6 as a therapeutic target for lymphoma
Leeman‐Neill, R. J., & Bhagat, G. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1420782 · Cited by 89
Targeting recognition surfaces on natural proteins with peptidic foldamers
Checco, J. W., & Gellman, S. H. (2016) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2016.06.014 · Cited by 88
Small-Molecule Inhibitors of IL-2/IL-2R: Lessons Learned and Applied
Wilson, C. G. M., & Arkin, M. R. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_93 · Cited by 86
Catrow, J. L., Zhang, Y., Zhang, M., & Ji, H. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00223 · Cited by 85
Inhibitors of PEX14 disrupt protein import into glycosomes and kill Trypanosoma parasites
Dawidowski, M., Emmanouilidis, L., Kalel, V. C., Tripsianes, K., Schorpp, K., Hadian, K., Kaiser, M., Mäser, P., Kolonko, M., Tanghe, S., et al. (2017) · Science · doi:10.1126/science.aal1807 · Cited by 81
Siegert, T. R., Bird, M. J., Makwana, K. M., & Kritzer, J. A. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b05656 · Cited by 79
Direct and Propagated Effects of Small Molecules on Protein–Protein Interaction Networks
Cesa, L. C., Mapp, A. K., & Gestwicki, J. E. (2015) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2015.00119 · Cited by 73
Self-citationA Chemical Inhibitor of the Skp2/p300 Interaction that Promotes p53‐Mediated Apoptosis
Oh, M., Lee, J. H., Moon, H., Hyun, Y.-J., & Lim, H. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201508716 · Cited by 68
Xu, S., Aguilar, A., Xu, T., Zheng, K., Huang, L., Stuckey, J. A., Chinnaswamy, K., Bernard, D., Fernández‐Salas, E., Liu, L., et al. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201711828 · Cited by 68
Structural Basis of Small-Molecule Aggregate Induced Inhibition of a Protein–Protein Interaction
Blevitt, J. M., Hack, M. D., Herman, K. L., Jackson, P., Krawczuk, P. J., Lebsack, A. D., Liu, A. X., Mirzadegan, T., Nelen, M. I., Patrick, A. N., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01836 · Cited by 66
Wang, X., Wu, X., Zhang, A., Wang, S., Hu, C., Chen, W., Shen, Y., Tan, R. X., Sun, Y., & Xu, Q. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.03.042 · Cited by 65
Yap, J. L., Cao, X. X., Vanommeslaeghe, K., Jung, K., Peddaboina, C. S., Wilder, P. T., Nan, A., MacKerell, A. D., Smythe, W. R., & Fletcher, S. (2012) · Organic & Biomolecular Chemistry · doi:10.1039/c2ob07125h · Cited by 63
Development of Selective CBP/P300 Benzoxazepine Bromodomain Inhibitors
Popp, T. A., Tallant, C., Rogers, C. M., Fedorov, O., Brennan, P. E., Müller, S., Knapp, S., & Bracher, F. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00774 · Cited by 63
Nanomolar Inhibitors of the Transcription Factor STAT5b with High Selectivity over STAT5a
Elumalai, N., Berg, A., Natarajan, K., Scharow, A., & Berg, T. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201410672 · Cited by 62
Design and Evolution of a Macrocyclic Peptide Inhibitor of the Sonic Hedgehog/Patched Interaction
Owens, A. E., de Paola, I., Hansen, W. A., Liu, Y., Khare, S. D., & Fasan, R. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b06087 · Cited by 61
From Fuzzy to Function: The New Frontier of Protein–Protein Interactions
Pricer, R. E., Gestwicki, J. E., & Mapp, A. K. (2017) · Accounts of Chemical Research · doi:10.1021/acs.accounts.6b00565 · Cited by 57
Self-citationIdentification of an Iridium(III)-Based Inhibitor of Tumor Necrosis Factor-α
Kang, T., Mao, Z., Ng, C. E., Wang, M., Wang, W., Wang, C., Lee, S. M., Wang, Y., Leung, C., & Ma, D. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00112 · Cited by 56
Discovery of peptide inhibitors targeting human programmed death 1 (PD-1) receptor
Li, Q., Quan, L., Lyu, J., He, Z., Wang, X., Meng, J., Zhao, Z., Zhu, L., Liu, X., & Li, H. (2016) · Oncotarget · doi:10.18632/oncotarget.11274 · Cited by 56
Kim, J., Jung, J., Koo, J., Cho, W., Lee, W. S., Kim, C., Park, W., & Park, S. B. (2016) · Nature Communications · doi:10.1038/ncomms13196 · Cited by 55
Lanning, M. E., Yu, W., Yap, J. L., Chauhan, J., Chen, L., Whiting, E., Pidugu, L. S. M., Atkinson, T., Bailey, H., Li, W., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.02.006 · Cited by 54
Wojcik, J. B., Lamontanara, A. J., Grabe, G. J., Koide, A., Akin, L. R., Gerig, B., Hantschel, O. D., & Koide, S. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.707901 · Cited by 54
A Small‐Molecule Protein–Protein Interaction Inhibitor of PARP1 That Targets Its BRCT Domain
Na, Z., Peng, B., Ng, S., Pan, S., Lee, J., Shen, H., & Yao, S. Q. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201410678 · Cited by 51
Yasuda, D., Nakajima, M., Yuasa, A., Obata, R., Takahashi, K., Ohe, T., Ichimura, Y., Komatsu, M., Yamamoto, M. P., Imamura, R. M., et al. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.10.083 · Cited by 50
Zhao, Y., Bai, L., Liu, L., McEachern, D., Stuckey, J. A., Meagher, J. L., Yang, C., Xu, R., Zhou, B. N., Hu, Y., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00193 · Cited by 48
Kawakami, T., Ogawa, K., Hatta, T., Goshima, N., & Natsume, T. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b01014 · Cited by 47
Sable, R. V., Durek, T., Taneja, V., Craik, D. J., Pallerla, S., Gauthier, T. J., & Jois, S. D. S. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00486 · Cited by 47
He, B., Tjhung, K. F., Bennett, N. J., Chou, Y., Rau, A., Huang, J. H., & Derda, R. (2018) · Scientific Reports · doi:10.1038/s41598-018-19439-2 · Cited by 44
Intracellular Generation of a Diterpene-Peptide Conjugate that Inhibits 14-3-3-Mediated Interactions
Parvatkar, P. T., Kato, N., Uesugi, M., Sato, S., & Ohkanda, J. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b09817 · Cited by 42
Wang, N., Lodge, J. M., Fierke, C. A., & Mapp, A. K. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406033111 · Cited by 41
Jendrny, C., & Beck‐Sickinger, A. G. (2015) · ChemBioChem · doi:10.1002/cbic.201500539 · Cited by 39
Voter, A. F., Manthei, K. A., & Keck, J. L. (2016) · SLAS DISCOVERY · doi:10.1177/1087057116635503 · Cited by 39
Mansilla, A., Chaves-Sanjuán, A., Campillo, N. E., Σεμελίδου, Ο., Martínez‐González, L., Infantes, L., González-Rubio, J. M., Gil, C., Conde, S., Skoulakis, E. M. C., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1611089114 · Cited by 39
Anticancer osmium complex inhibitors of the HIF-1α and p300 protein-protein interaction
Yang, C., Wang, W., Li, G., Zhong, H., Dong, Z., Wong, C., Kwong, D. W. J., Ma, D., & Leung, C. (2017) · Scientific Reports · doi:10.1038/srep42860 · Cited by 39
Small-Molecule Protein-Protein Interaction Inhibitor of Oncogenic Rho Signaling
Diviani, D., Raimondi, F., del Vescovo, C. D., Dreyer, E., Reggi, E., Osman, H., Ruggieri, L., Gonano, C., Cavin, S., Box, C. L., et al. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2016.07.015 · Cited by 37
Phage Selection of Peptide Macrocycles against β‐Catenin To Interfere with Wnt Signaling
Bertoldo, D., Maola, K. M. G., Dessen, P., Held, W., Huelsken, J., & Heinis, C. (2016) · ChemMedChem · doi:10.1002/cmdc.201500557 · Cited by 36
Bisson, M. M. A., Kessenbrock, M., Müller, L., Hofmann, A., Schmitz, F., Cristescu, S. M., & Groth, G. (2016) · Scientific Reports · doi:10.1038/srep30634 · Cited by 36
Polar Recognition Group Study of Keap1-Nrf2 Protein–Protein Interaction Inhibitors
Lu, M., Tan, S.-J., Ji, J., Chen, Z., Yuan, Z., You, Q., & Jiang, Z. (2016) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00407 · Cited by 35
de Araujo, A. D., Lim, J., Good, A. C., Skerlj, R. T., & Fairlie, D. P. (2016) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6b00395 · Cited by 35
Proapoptotic modification of substituted isoindolinones as MDM2-p53 inhibitors
Grigoreva, T. A., Novikova, D., Petukhov, A., Gureev, M., Garabadzhiu, A. V., Melino, G., Barlev, N. A., & Tribulovich, V. G. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.10.049 · Cited by 35
Singh, R., Sran, A. S., Carroll, D. C., Huang, J., Tsvetkov, L. M., Zhou, X., Sheung, J., McLaughlin, J., Issakani, S. D., Payan, D. G., et al. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.09.067 · Cited by 33
Inhibition of Canonical NF-κB Signaling by a Small Molecule Targeting NEMO-Ubiquitin Interaction
Vincendeau, M., Hadian, K., Messias, A. C., Brenke, J. K., Halander, J., Griesbach, R. A., Greczmiel, U., Bertossi, A., Stehle, R., Nagel, D., et al. (2016) · Scientific Reports · doi:10.1038/srep18934 · Cited by 33
Yasuda, D., Yuasa, A., Obata, R., Nakajima, M., Takahashi, K., Ohe, T., Ichimura, Y., Komatsu, M., Yamamoto, M. P., Imamura, R. M., et al. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.10.008 · Cited by 33
Curtin, M. L., Pliushchev, M. A., Li, H., Torrent, M., Dietrich, J. D., Jakob, C. G., Zhu, H., Zhao, H., Wang, Y., Ji, Z., et al. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.02.030 · Cited by 31
Drennen, B., Scheenstra, J. A., Yap, J. L., Chen, L., Lanning, M. E., Roth, B. M., Wilder, P. T., & Fletcher, S. (2016) · ChemMedChem · doi:10.1002/cmdc.201500461 · Cited by 30
Novel DOCK2-selective inhibitory peptide that suppresses B-cell line migration
Sakamoto, K., Adachi, Y., Komoike, Y., Kamada, Y., Koyama, R., Fukuda, Y., Kadotani, A., Asami, T., & Sakamoto, J. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.12.170 · Cited by 29
Modulating Protein-Protein Interactions of the Mitotic Polo-like Kinases to Target Mutant KRAS
Narvaez, A. J., Ber, S., Crooks, A. T., Emery, A., Hardwick, B. S., Guarino, E., Huggins, D. J., Perera, D., Roberts-Thomson, M., Azzarelli, R., et al. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.07.009 · Cited by 29
Discovery of a Potent Allosteric Kinase Modulator by Combining Computational and Synthetic Methods
Kroon, E., Schulze, J. O., Süß, E., Camacho, C. J., Biondi, R. M., & Dömling, A. S. S. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201506310 · Cited by 27
Mistry, I. N., & Tavassoli, A. (2016) · ACS Synthetic Biology · doi:10.1021/acssynbio.6b00219 · Cited by 27
Discovery of a small-molecule inhibitor of STAT3 by ligand-based pharmacophore screening
Leung, K., Liu, L., Lin, S., Lu, L., Zhong, H., Susanti, D., Rao, W., Wang, M., Che, W. I., Chan, D. S., et al. (2014) · Methods · doi:10.1016/j.ymeth.2014.07.010 · Cited by 26
Inhibition of the p53/hDM2 protein-protein interaction by cyclometallated iridium(III) compounds
Liu, L., He, B., Miles, J. A., Wang, W., Mao, Z., Che, W. I., Lu, J., Chen, X., Wilson, A. J., Ma, D., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7369 · Cited by 26
Male, A. L., Forafonov, F., Cuda, F., Zhang, G., Zheng, S., Oyston, P. C. F., Chen, P. R., Williamson, E. D., & Tavassoli, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-03253-3 · Cited by 26
Xu, R., Liu, L., Yang, C., Lu, J., Chen, Y., Lei, M., & Wang, S. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01465 · Cited by 25
Discovery of Enzymatic Targets of Transcriptional Activators via in Vivo Covalent Chemical Capture
Dugan, A., Majmudar, C. Y., Pricer, R. E., Niessen, S., Lancia, J., Fung, H., Cravatt, B., & Mapp, A. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b07680 · Cited by 25
Li, D., Wang, Z., Chen, W., Xie, Y.-Y., You, Q., & Guo, X. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.09.073 · Cited by 24
Kessenbrock, M., Klein, S., Müller, L., Hunsche, M., Noga, G. J., & Groth, G. (2017) · Frontiers in Plant Science · doi:10.3389/fpls.2017.01528 · Cited by 24
Trapping of the Enoyl-Acyl Carrier Protein Reductase–Acyl Carrier Protein Interaction
Tallorin, L., Finzel, K. L., Nguyen, Q. G., Beld, J., Clair, J. J. L., & Burkart, M. D. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.5b13456 · Cited by 23
The polar warhead of a TRIM 24 bromodomain inhibitor rearranges a water‐mediated interaction network
Liu, J., Li, F., Bao, H., Jiang, Y., Zhang, S., Ma, R., Gao, J., Wu, J., & Ruan, K. (2017) · FEBS Journal · doi:10.1111/febs.14041 · Cited by 23
Hayes, M. P., Soto‐Velasquez, M., Fowler, C. A., Watts, V. J., & Roman, D. L. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00349 · Cited by 23
Martín‐Quirós, A., Nevola, L., Eckelt, K., Madurga, S., Gorostiza, P., & Giralt, E. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.10.022 · Cited by 21
Dickson, H. M., Wilbur, A., Reinke, A. A., Young, M. A., & Vojtek, A. B. (2015) · BMC Neuroscience · doi:10.1186/s12868-015-0171-5 · Cited by 20
Lee, J. H., Oh, M., Kim, H. S., Lee, H., Im, W., & Lim, H. (2015) · ACS Combinatorial Science · doi:10.1021/acscombsci.5b00080 · Cited by 20
Mouhsine, H., Guillemain, H., Moreau, G., Fourati, N., Zerrouki, C., Baron, B., Desallais, L., Gizzi, P., Nasr, N. B., Perrier, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-03427-z · Cited by 20
Discovery of Mcl-1 inhibitors based on a thiazolidine-2,4-dione scaffold
Whiting, E., Raje, M. R., Chauhan, J., Wilder, P. T., Eker, D. V., Hughes, S. J., Bowen, N. G., Vickers, G. E. A., Fenimore, I. C., & Fletcher, S. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.11.023 · Cited by 20
Crystal structure of alpha-beta-foldamer 2c in complex with Bcl-xL
Boersma, M., Haase, H. S., Peterson‐Kaufman, K. J., et al. (2011) · Worldwide Protein Data Bank · doi:10.2210/pdb4a1u/pdb · Cited by 20
Liu, D., Xu, D. D., Liu, M., Knabe, W. E., Yuan, C., Zhou, D., Huang, M., & Meroueh, S. O. (2017) · Biochemistry · doi:10.1021/acs.biochem.6b01039 · Cited by 19
Kanthala, S., Liu, Y., Singh, S. S., Sable, R. V., Pallerla, S., & Jois, S. D. S. (2017) · Oncotarget · doi:10.18632/oncotarget.19013 · Cited by 18
Targeting the apoptotic Mcl-1-PUMA interface with a dual-acting compound
Liu, J., Tian, Z., Zhou, N., Liu, X., Liao, C., Lei, B., Li, J., Zhang, S., & Chen, H. (2017) · Oncotarget · doi:10.18632/oncotarget.17294 · Cited by 16
A Small Covalent Allosteric Inhibitor of Human Cytomegalovirus DNA Polymerase Subunit Interactions
Chen, H., Coseno, M., Ficarro, S. B., Mansueto, M. S., Komazin-Meredith, G., Boissel, S., Filman, D. J., Marto, J. A., Hogle, J. M., & Coen, D. M. (2016) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.6b00079 · Cited by 15
Sogabe, S., Sakamoto, K., Kamada, Y., Kadotani, A., Fukuda, Y., & Sakamoto, J. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.03.038 · Cited by 15
Rational design and screening of peptide-based inhibitors of heat shock factor 1 (HSF1)
Xu, R., Burchfiel, E. T., Dong, B., Rettko, N. J., Dunyak, B. M., Shao, H., Thiele, D. J., & Gestwicki, J. E. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.04.018 · Cited by 13
Self-citationMorimoto, J., Hosono, Y., & Sando, S. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.01.001 · Cited by 10
Design and synthesis of benzylpiperidine inhibitors targeting the menin–MLL1 interface
Ren, J., Xü, W., Tang, L., Su, M., Chen, D., Chen, Y.-L., Zang, Y., Li, J., Shen, J., Zhou, Y., et al. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.07.074 · Cited by 9
Protein–Protein Interaction Inhibitors of BRCA1 Discovered Using Small Molecule Microarrays
Na, Z., Pan, S., Uttamchandani, M., & Yao, S. Q. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6584-7_10 · Cited by 9
Macrocyclization and labeling of helix–loop–helix peptide with intramolecular bis‐thioether linkage
Nishihara, T., Kitada, H., Fujiwara, D., & Fujii, I. (2016) · Biopolymers · doi:10.1002/bip.22826 · Cited by 8
Cited by
Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy: A Translational Perspective
Nattel, S., Heijman, J., Zhou, L., & Dobrev, D. (2020) · Circulation Research · doi:10.1161/circresaha.120.316363 · Cited by 440
Exploring new targets and chemical space with affinity selection-mass spectrometry
Prudent, R., Annis, D. A., Dandliker, P. J., Ortholand, J.-Y., & Roche, D. (2020) · Nature Reviews Chemistry · doi:10.1038/s41570-020-00229-2 · Cited by 104
Bifunctional chemical probes inducing protein–protein interactions
Maniaci, C., & Ciulli, A. (2019) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2019.07.003 · Cited by 100
Ciccone, L., Shi, C., di Lorenzo, D., Van Baelen, A.-C., & Tonali, N. (2020) · Molecules · doi:10.3390/molecules25102439 · Cited by 69
Fan, Z., Tian, Y., Chen, Z., Liu, L., Zhou, Q., He, J., Coleman, J., Dong, C., Li, N., Huang, J., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201911571 · Cited by 62
“Currently, PPIs are targeted by an increasingly larger number of small molecular chemicals (Ran & Gestwicki, 2018).”
Background
Metadata
- Authors
- Ran, X., & Gestwicki, J. E.
- Venue
- Current Opinion in Chemical Biology
- Publisher
- Elsevier BV
- Published
- 2018-06
- Volume
- 44
- Pages
- 75-86
- ISSN
- 1367-5931 (ISSN-L)
- OpenAlex
- W2808147451
- Cited by
- 263
- References
- 125
- FWCI
- 1.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.